AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

FLIBANSERIN 100 Mg ;

10 registrations across 1 African market— 10 active

Markets with FLIBANSERIN 100 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Flibanoact
Tablets
🇪🇬EgyptAUG Pharmaactive
Flibafemina
Film Coated Tablets
🇪🇬EgyptMarcyrl pharmaceutical industries - MPIactive
Veroxeserin
Film Coated Tablets
🇪🇬EgyptHikma Pharmaceuticals industriesactive
Aphrofemine
Film Coated Tablets
🇪🇬EgyptBio Med For Pharmaceutical Industries (BIOMED)active
Amorgrace
Film Coated Tablets
🇪🇬EgyptOmega pharmaceutical and chemical industries - OPCIactive
Amorgrace
Film Coated Tablets
🇪🇬EgyptOmega pharmaceutical and chemical industries - OPCIactive
Flibanoact
Tablets
🇪🇬EgyptAUG Pharmaactive
Aphrofemine
Film Coated Tablets
🇪🇬EgyptBio Med For Pharmaceutical Industries (BIOMED)active
Flibafemina
Film Coated Tablets
🇪🇬EgyptMarcyrl pharmaceutical industries - MPIactive
Veroxeserin
Film Coated Tablets
🇪🇬EgyptHikma Pharmaceuticals industriesactive

FLIBANSERIN 100 Mg ; in Africa — Regulatory Overview

FLIBANSERIN 100 Mg ; is registered across 1 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 10 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.